WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.3% of their position (22.50K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $3.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/15/2021ACC: 0001213900-21-065395
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+22.50K
Net shares
Net buyer
$3.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
22.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$0.16
Trade value
$777.00
% of position
0.1%
12/10/2021
7.69M→7.69M
Common Stock
Direct
Shares
+17.50K
Price / share
$0.14
Trade value
$2.41K
% of position
0.2%
12/13/2021
7.69M→7.71M
Total
Net shares
+22.50K
Net value
$3.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2021 | P · Purchase | +5K | $0.16 | $777.00 | 0.1% | 7.69M | 7.69M |
| Common Stock Direct | 12/13/2021 | P · Purchase | +17.50K | $0.14 | $2.41K | 0.2% | 7.69M | 7.71M |
| Total | +22.50K | $3.19K | ||||||
Derivative Transactions0
No derivative transactions reported